Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteActive in the last 2 years

Nobuyasu Fukutake

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5030870685. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 3 papers · 2021: 3 papers · 2022: 3 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 13

  1. Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75 Years and Older With Unresectable Pancreatic C… Co-author DOI 10.1002/cnr2.70691↗
  2. Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic ca… Co-author DOI 10.1055/a-1713-3404↗
  3. Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic ca… Co-author DOI 10.1371/journal.pone.0264653↗
  4. New Screening System Using Forward-Viewing Radial Endoscopic Ultrasound and Magnetic Resonance Imaging for High-Risk Individuals With Familial History of Pancr… Co-author DOI 10.3389/fmed.2022.928182↗
  5. Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S-1 as second-line chemotherapy in metastat… Co-author DOI 10.1002/jgh3.12555↗
  6. Predictive Factors for Pancreatic Cancer and Its Early Detection Using Special Pancreatic Ultrasonography in High-Risk Individuals. Co-author DOI 10.3390/cancers13030502↗
  7. The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Ca… Co-author DOI 10.3390/cancers13184733↗
  8. Efficacy of Larger-Diameter Plastic Stent Placement for Preoperative Biliary Drainage in Patients Receiving Neoadjuvant Chemoradiation for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001509↗
  9. Clinical Utility of Pancreatic Cancer Circulating Tumor DNA in Predicting Disease Progression, Prognosis, and Response to Chemotherapy. Co-author DOI 10.1097/mpa.0000000000001652↗
  10. Endoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer. First author DOI 10.4251/wjgo.v12.i7.768↗
  11. A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile. Co-author DOI 10.1371/journal.pone.0132223↗
  12. Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1. Co-author DOI 10.1159/000364819↗
  13. Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. Co-author DOI 10.1007/s00535-012-0693-x↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ryoji Takada · 11 shared papers, 2014–2026 · strength 1.39
  2. Kazuyoshi Ohkawa · 11 shared papers, 2013–2026 · strength 1.38
  3. Kenji Ikezawa · 10 shared papers, 2013–2026 · strength 1.27
  4. Takuo Yamai · 8 shared papers, 2014–2026 · strength 1.01
  5. Reiko Ashida · 8 shared papers, 2014–2022 · strength 0.84
  6. Yugo Kai · 5 shared papers, 2021–2026 · strength 0.76
  7. Hidenori Takahashi · 6 shared papers, 2020–2022 · strength 0.72
  8. Kazuhiro Katayama · 5 shared papers, 2020–2021 · strength 0.53
  9. Makiko Urabe · 3 shared papers, 2021–2026 · strength 0.52
  10. Tatsuya Ioka · 5 shared papers, 2013–2022 · strength 0.46
  11. Shigenori Nagata · 3 shared papers, 2021–2022 · strength 0.40
  12. Kazuma Daiku · 3 shared papers, 2021–2022 · strength 0.34
  13. Teruki Teshima · 2 shared papers, 2020–2021 · strength 0.22
  14. Hirofumi Akita · 2 shared papers, 2020–2021 · strength 0.22
  15. Sachiko Tanaka · 2 shared papers, 2013–2021 · strength 0.14
  16. Shinichiro Hasegawa · 1 shared paper, 2022 · strength 0.13
  17. Hisataka Ogawa · 1 shared paper, 2022 · strength 0.13
  18. Tomoya Ekawa · 1 shared paper, 2022 · strength 0.13
  19. Hideaki Tahara · 1 shared paper, 2022 · strength 0.13
  20. Yasuharu Kawamoto · 1 shared paper, 2022 · strength 0.13
  21. Kazuhiro Katayama · 3 shared papers, 2013–2015 · strength 0.12
  22. Shingo Ohira · 1 shared paper, 2020 · strength 0.11
  23. Junko Fukuda · 1 shared paper, 2021 · strength 0.11
  24. Kikuya Kato · 1 shared paper, 2020 · strength 0.10
  25. Yoji Kukita · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.